Burger, D M <br/><br/>
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Mar 2001 
 - 701-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.45.3.701-705.2001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Area Under Curve<br/>Child<br/>Child, Preschool<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--blood<br/>HIV-1--drug effects<br/>Humans<br/>Indinavir--blood<br/>Infant<br/>Male<br/>Prospective Studies